A decade-long follow-up study of recreational marathon runners has concluded that the cardiac stress of 26.2 miles does not translate into measurable long-term damage to heart function, offering some of the most robust evidence yet in a debate that has swung back and forth through the sports cardiology literature for nearly twenty years. The research, published in JAMA Cardiology and covered this week across several medical and mainstream outlets, followed 152 middle-aged runners through multiple marathon cycles and compared their cardiac imaging against baseline data collected a decade earlier.
The study focused on the right ventricle, which has been at the centre of the long-running "athlete's heart" debate because it is known to bear a disproportionate load during sustained aerobic exertion. Researchers did find a short-term drop in right-ventricular pumping ability immediately after marathon races, consistent with earlier work, but those changes resolved within days of race completion. Across the full ten-year window, there was no evidence of cumulative damage, no measurable reduction in overall heart function, and no statistically elevated rate of adverse cardiac events in the study cohort.
The findings complicate, rather than end, the broader discussion. A body of earlier research — including a widely-cited 2010 MRI study of less fit runners — had suggested that marathon running in under-prepared athletes could lead to heart changes lasting up to three months, with some evidence of more widespread abnormal heart segments in those with lower aerobic capacity. The new JAMA Cardiology work does not contradict those findings directly, because its cohort was better-trained than the 2010 study's. What it does establish is that the kind of recreationally serious runner who shows up on a well-structured training plan can race marathons through their forties and fifties without paying a long-term cardiac price.
Embedded in the data is a cautionary undercurrent. The authors note that the transient right-ventricular dysfunction seen immediately after racing was less pronounced in runners with higher baseline aerobic capacity, echoing the older literature that implicated inadequate preparation rather than the race itself as the mechanism of risk. Runners entering a marathon undertrained, or without having completed a meaningful volume block, are likely still at elevated risk of exaggerated cardiac strain. That message is not new, but it remains relevant at a moment when ballot expansions at major city marathons are bringing an ever-wider range of preparation levels to the start line.
For the running medicine community, the study is likely to be most useful as a counterweight to the sensationalist framing that still dominates coverage of cardiac events at mass participation races. The authors argue that the picture is now clear enough to support a more nuanced public-health message: marathons are not intrinsically damaging to the heart, but the training that precedes them matters enormously. The finding dovetails with the broader 2026 research push toward personalised risk models for endurance athletes — including the machine learning injury work we covered earlier this month — which is gradually moving the sport away from one-size-fits-all cautions and toward individual physiology as the relevant unit of analysis.